Action GMO International Qualit...

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

24,6717

Prix Achat

Prix Vente

Volume échangé

462 696

24,4901 Fourchette du Jour 24,91

22,49 Plage de 52 semaines 25,46

Clôture Veille

25,0984

Ouverture

24,80

Dernière Transaction

100

24.6717

Dernière heure de transaction

Volume moyen (3 m)

13 720

Volume financier

US$ 11 414 161

VWAP

24,6688

QLT Inc. establishes sales force in the United States

- QLT Ophthalmics, Inc. will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec. 22 /PRNewswire-FirstCall/ -- QLT Inc...

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

VANCOUVER, Dec. 15 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has initiated...

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") welcomed the 6-month results from the...

QLT announces MGH litigation settlement

VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the settlement of its...

QLT announces Toronto Stock Exchange approval of share repurchase program

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT") announced that the Toronto Stock Exchange ("TSX") has...

QLT Announces Share Repurchase Program

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that its board of...

QLT announces third quarter results for 2009

QLT SEPARATELY ANNOUNCES SHARE REPURCHASE PROGRAM VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the...

QLT restructures Visudyne(R) agreement

RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON SALES OUTSIDE THE U.S. VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ -- QLT Inc...

QLT announces sale of QLT USA, Inc. for up to US$230 million

VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the...

QLT announces receipt of a CDN$45.3 million tax refund

VANCOUVER, Sept. 8 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has received an...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.1417	0.577660008153	24.53	25.28	24.4401	26199	25.01027844	SP
4	0.6617	2.75593502707	24.01	25.35	23.97	10986	24.77338952	SP
12	1.0217	4.3200845666	23.65	25.46	22.49	13720	23.75914495	SP
26	-0.1783	-0.717505030181	24.85	25.46	22.49	12381	23.8068902	SP
52	-0.1783	-0.717505030181	24.85	25.46	22.49	12381	23.8068902	SP
156	-0.1783	-0.717505030181	24.85	25.46	22.49	12381	23.8068902	SP
260	-0.1783	-0.717505030181	24.85	25.46	22.49	12381	23.8068902	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GMO International Quality ETF (QLTI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

QLTI Dernières nouvelles

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GMO International Quality ETF (QLTI) Cours

GMO International Quality ETF (QLTI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

QLTI Dernières nouvelles

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités